drugset / Trial / NCT03971123

Study to Compare the Pharmacokinetics of Tricaprilin Formulations and a Placebo on Ketone Body Production

NCT03971123 ↗

Phase 1 Completed 32 enrolled Cerecin
RandomizedCrossoverOpen-labelBasic science

Summary

Phase 1, Single-center, Open-label Study, Healthy Adult Male Subjects. Part 1:Single-dose, Placebo-controlled, 3-Way Crossover PK Study Part 2: Single dose 2-way comparator PK Study

Timeline

Start
2019-08-30
Primary completion
2020-04-02
Completion
2020-05-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Tricaprilin Other / unclassified 20 g Oral

Indications